---
{"dg-publish":true,"permalink":"/test/insights/fasting-for-3-days-reduces-igf-1-levels-by-as-much-as-54/"}
---

<span>Circle</span>

<span>Circle</span>

<div><table class="dataview table-view-table"><thead class="table-view-thead"><tr class="table-view-tr-header"><th class="table-view-th"><span>Content Sources</span><span class="dataview small-text">11</span></th></tr></thead><tbody class="table-view-tbody"><tr><td><span><a data-tooltip-position="top" aria-label="Test/Insights/Refeeding after an FMD causes senescent cells of various types throughout the body to die off.md" data-href="Test/Insights/Refeeding after an FMD causes senescent cells of various types throughout the body to die off.md" href="Test/Insights/Refeeding after an FMD causes senescent cells of various types throughout the body to die off.md" class="internal-link" target="_blank" rel="noopener">Refeeding after an FMD causes senescent cells of various types throughout the body to die off</a></span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Test/Insights/Refeeding after an FMD cycle causes a reduction in senescent LT-HSCs specifically due to apoptosis.md" data-href="Test/Insights/Refeeding after an FMD cycle causes a reduction in senescent LT-HSCs specifically due to apoptosis.md" href="Test/Insights/Refeeding after an FMD cycle causes a reduction in senescent LT-HSCs specifically due to apoptosis.md" class="internal-link" target="_blank" rel="noopener">Refeeding after an FMD cycle causes a reduction in senescent LT-HSCs specifically due to apoptosis</a></span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Test/Insights/There are fewer senescent LT-HSCs in the bone marrow 24 hours after refeeding following two consecutive FMD cycles.md" data-href="Test/Insights/There are fewer senescent LT-HSCs in the bone marrow 24 hours after refeeding following two consecutive FMD cycles.md" href="Test/Insights/There are fewer senescent LT-HSCs in the bone marrow 24 hours after refeeding following two consecutive FMD cycles.md" class="internal-link" target="_blank" rel="noopener">There are fewer senescent LT-HSCs in the bone marrow 24 hours after refeeding following two consecutive FMD cycles</a></span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Test/Insights/Refeeding, but not the FMD itself, causes apoptosis in senescent LT-HSCs in the bone marrow following two consecutive FMD cycles.md" data-href="Test/Insights/Refeeding, but not the FMD itself, causes apoptosis in senescent LT-HSCs in the bone marrow following two consecutive FMD cycles.md" href="Test/Insights/Refeeding, but not the FMD itself, causes apoptosis in senescent LT-HSCs in the bone marrow following two consecutive FMD cycles.md" class="internal-link" target="_blank" rel="noopener">Refeeding, but not the FMD itself, causes apoptosis in senescent LT-HSCs in the bone marrow following two consecutive FMD cycles</a></span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Test/Insights/The % of cas3+p16+ LT-HSCs increases from ~1% to ~3% in the bone marrow of 22-month-old mice at 24 hours after refeeding following two consecutive FMD cycles.md" data-href="Test/Insights/The % of cas3+p16+ LT-HSCs increases from ~1% to ~3% in the bone marrow of 22-month-old mice at 24 hours after refeeding following two consecutive FMD cycles.md" href="Test/Insights/The % of cas3+p16+ LT-HSCs increases from ~1% to ~3% in the bone marrow of 22-month-old mice at 24 hours after refeeding following two consecutive FMD cycles.md" class="internal-link" target="_blank" rel="noopener">The % of cas3+p16+ LT-HSCs increases from ~1% to ~3% in the bone marrow of 22-month-old mice at 24 hours after refeeding following two consecutive FMD cycles</a></span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Test/Insights/The % of cas3+p16+ LT-HSCs in the bone marrow of 22-month-old mice is not affected by an FMD cycle.md" data-href="Test/Insights/The % of cas3+p16+ LT-HSCs in the bone marrow of 22-month-old mice is not affected by an FMD cycle.md" href="Test/Insights/The % of cas3+p16+ LT-HSCs in the bone marrow of 22-month-old mice is not affected by an FMD cycle.md" class="internal-link" target="_blank" rel="noopener">The % of cas3+p16+ LT-HSCs in the bone marrow of 22-month-old mice is not affected by an FMD cycle</a></span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Test/Insights/The % of cas3+ LT-HSCs increases from ~1% to ~3% in the bone marrow of 22-month-old mice at 24 hours after refeeding following two consecutive FMD cycles.md" data-href="Test/Insights/The % of cas3+ LT-HSCs increases from ~1% to ~3% in the bone marrow of 22-month-old mice at 24 hours after refeeding following two consecutive FMD cycles.md" href="Test/Insights/The % of cas3+ LT-HSCs increases from ~1% to ~3% in the bone marrow of 22-month-old mice at 24 hours after refeeding following two consecutive FMD cycles.md" class="internal-link" target="_blank" rel="noopener">The % of cas3+ LT-HSCs increases from ~1% to ~3% in the bone marrow of 22-month-old mice at 24 hours after refeeding following two consecutive FMD cycles</a></span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Test/Insights/The % of cas3+ LT-HSCs in the bone marrow of 22-month-old mice is not affected by an FMD cycle.md" data-href="Test/Insights/The % of cas3+ LT-HSCs in the bone marrow of 22-month-old mice is not affected by an FMD cycle.md" href="Test/Insights/The % of cas3+ LT-HSCs in the bone marrow of 22-month-old mice is not affected by an FMD cycle.md" class="internal-link" target="_blank" rel="noopener">The % of cas3+ LT-HSCs in the bone marrow of 22-month-old mice is not affected by an FMD cycle</a></span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Test/Insights/p16 expression is reduced in LT-HSCs in the bone marrow of 22-month-old mice at 24 hours after refeeding following two consecutive FMD cycles.md" data-href="Test/Insights/p16 expression is reduced in LT-HSCs in the bone marrow of 22-month-old mice at 24 hours after refeeding following two consecutive FMD cycles.md" href="Test/Insights/p16 expression is reduced in LT-HSCs in the bone marrow of 22-month-old mice at 24 hours after refeeding following two consecutive FMD cycles.md" class="internal-link" target="_blank" rel="noopener">p16 expression is reduced in LT-HSCs in the bone marrow of 22-month-old mice at 24 hours after refeeding following two consecutive FMD cycles</a></span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Test/Insights/Whole-body senescence in mice may be reduced at the end of a FMD cycle.md" data-href="Test/Insights/Whole-body senescence in mice may be reduced at the end of a FMD cycle.md" href="Test/Insights/Whole-body senescence in mice may be reduced at the end of a FMD cycle.md" class="internal-link" target="_blank" rel="noopener">Whole-body senescence in mice may be reduced at the end of a FMD cycle</a></span></td></tr><tr><td><span><a data-tooltip-position="top" aria-label="Test/Insights/Whole-body expression of p16 is reduced in 11-month-old mice at the end of a second consecutive monthly FMD cycle.md" data-href="Test/Insights/Whole-body expression of p16 is reduced in 11-month-old mice at the end of a second consecutive monthly FMD cycle.md" href="Test/Insights/Whole-body expression of p16 is reduced in 11-month-old mice at the end of a second consecutive monthly FMD cycle.md" class="internal-link" target="_blank" rel="noopener">Whole-body expression of p16 is reduced in 11-month-old mice at the end of a second consecutive monthly FMD cycle</a></span></td></tr></tbody></table></div>


Source_Content:: [[Test/Source Content/longoUtilizationFastingMimickingDiet2023 - figure 1A\|longoUtilizationFastingMimickingDiet2023 - figure 1A]], [[Test/Source Content/longoUtilizationFastingMimickingDiet2023 - figure 1B\|longoUtilizationFastingMimickingDiet2023 - figure 1B]], [[Test/Source Content/longoUtilizationFastingMimickingDiet2023 - figure 1C\|longoUtilizationFastingMimickingDiet2023 - figure 1C]], [[Test/Source Content/longoUtilizationFastingMimickingDiet2023 - figure 1D\|longoUtilizationFastingMimickingDiet2023 - figure 1D]], [[Test/Source Content/longoUtilizationFastingMimickingDiet2023 - results and methods explanation referencing figure 1 (patent section 0066)\|longoUtilizationFastingMimickingDiet2023 - results and methods explanation referencing figure 1 (patent section 0066)]], [[Test/Source Content/longoUtilizationFastingMimickingDiet2023 - results explanation referencing figure 1 (patent section 0067)\|longoUtilizationFastingMimickingDiet2023 - results explanation referencing figure 1 (patent section 0067)]]
Supporting_Insights:: [[Test/Insights/Refeeding after an FMD causes senescent cells of various types throughout the body to die off\|Refeeding after an FMD causes senescent cells of various types throughout the body to die off]], [[Test/Insights/Refeeding after an FMD cycle causes a reduction in senescent LT-HSCs specifically due to apoptosis\|Refeeding after an FMD cycle causes a reduction in senescent LT-HSCs specifically due to apoptosis]]